‘Human-on-a-Chip’ Disease Model Can Potentially Test Therapies Better

‘Human-on-a-Chip’ Disease Model Can Potentially Test Therapies Better

312718

‘Human-on-a-Chip’ Disease Model Can Potentially Test Therapies Better

“Human-on-a-chip” technology developed by Hesperos can be used to model myasthenia gravis (MG), a new study shows. “This system has the potential to help researchers understand which mechanisms are driving a specific patient’s disease, including presence of particular autoantibodies [self-targeting antibodies], and could be used to further evaluate targeted therapeutic interventions,” Michael Shuler, PhD, president and CEO of Hesperos, said in a press release. The study, “A Functional Human-on-a-Chip Autoimmune Disease Model of Myasthenia Gravis…

You must be logged in to read/download the full post.